Abstract
Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on ‘Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus–Merzbacher disease patient with a partial PLP1 duplication’
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have